Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Primitive reflex, Hypsarrhythmia, Low muscle tone (hypotonia), and Severe global developmental delay and others; and common findings: Atonic seizure. 15 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 11 | Bilateral tonic-clonic seizure, Inability to walk, Focal clonic seizure |
ST3GAL3 function has not been fully characterized.
Developmental and epileptic encephalopathy, 15 is associated with mutations in the ST3GAL3 gene on chromosome 1.
Genetic testing for ST3GAL3 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for developmental and epileptic encephalopathy, 15 has been reported in the published literature.
Phenotype severity distribution: 8 always present features, 1 common feature.
No clinical trials have been registered for developmental and epileptic encephalopathy, 15.
211 publications have been identified in PubMed for developmental and epileptic encephalopathy, 15. Kisho has analyzed 161 by research type. Research spans Review / Meta-Analysis (22%), Basic Science / Preclinical (22%), and Epidemiology / Natural History (22%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 36 | 22% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Muscles |
1 |
Low muscle tone (hypotonia) |
Laboratory research |
36 |
22% |
Disease patterns and progression | 36 | 22% |
Patient case studies | 27 | 17% |
Clinical study results | 10 | 6% |
Testing and diagnosis research | 9 | 6% |
New treatment approaches | 6 | 4% |
Other research | 1 | 1% |
Sahu A (2026). [PMID: 42008890](https://pubmed.ncbi.nlm.nih.gov/42008890/). *Epilepsy Res*. [Epidemiology / Natural History]
Mondragon E (2026). [PMID: 41215607](https://pubmed.ncbi.nlm.nih.gov/41215607/). *Epilepsia*. [Basic Science / Preclinical]
Koles K (2026). [PMID: 41708000](https://pubmed.ncbi.nlm.nih.gov/41708000/). *J Biol Chem*. [Review / Meta-Analysis]
Sullivan J (2026). [PMID: 41251148](https://pubmed.ncbi.nlm.nih.gov/41251148/). *Epilepsia*. [Basic Science / Preclinical]
Pathiraja H (2026). [PMID: 42098868](https://pubmed.ncbi.nlm.nih.gov/42098868/). *J Med Case Rep*. [Case Report / Case Series]
Shah R (2026). [PMID: 41597222](https://pubmed.ncbi.nlm.nih.gov/41597222/). *Cells*. [Basic Science / Preclinical]
Millevert C (2026). [PMID: 40472023](https://pubmed.ncbi.nlm.nih.gov/40472023/). *Brain*. [Basic Science / Preclinical]
Kansal B (2026). [PMID: 41498396](https://pubmed.ncbi.nlm.nih.gov/41498396/). *Mov Disord Clin Pract*. [Clinical Trial Publication]
SanInocencio C (2026). [PMID: 41621282](https://pubmed.ncbi.nlm.nih.gov/41621282/). *Epilepsy Res*. [Review / Meta-Analysis]
de Oliveira HM (2026). [PMID: 42202442](https://pubmed.ncbi.nlm.nih.gov/42202442/). *Seizure*. [Review / Meta-Analysis]